PP
EPZM

Paloma Partners’s Epizyme, Inc EPZM Stock Holding History

Paloma Partners’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,775
Closed -$27K – 2423
2021
Q4 		$27K Buy
+10,775
New +$42.3K ﹤0.01% 1848
2020
Q4 		– Sell
-22,183
Closed -$265K – 2402
2020
Q3 		$265K Buy
+22,183
New +$297K 0.01% 1571
2013
Q4 		– Sell
-11,000
Closed -$441K – 1233
2013
Q3 		$441K Buy
+11,000
New +$373K 0.02% 523

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Paloma Partners's EPZM Position: Q1 2022 in Review

Paloma Partners sold out of Epizyme, Inc (EPZM) in Q1 2022, closing a stake of 10,775 shares — an estimated $27K sold.

Paloma Partners first reported a position in EPZM in Q3 2013 and held it in 3 quarters. The position peaked at $441K in Q3 2013. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

  • Paloma Partners reported no remaining Epizyme, Inc position as of Q1 2022 after selling out during the quarter.
  • Paloma Partners sold 10,775 Epizyme, Inc shares in Q1 2022, an estimated $27K.
  • Paloma Partners first reported a position in Epizyme, Inc in Q3 2013 and held it in 3 quarters.
  • Paloma Partners's Epizyme, Inc position peaked at $441K in Q3 2013.
  • 120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on Paloma Partners's 13F filing for Q1 2022, filed 16 May 2022.